Nicotinamide mononucleotide

Nicotinamide mononucleotide (CAS 1094-61-7), commonly abbreviated as NMN and also recognized commercially as beta-NMN, is a nucleotide derivative of niacinamide that functions as a direct biosynthetic precursor to NAD+.

Demand is driven by its role in supporting cellular energy metabolism pathways, making it a sought-after active ingredient across pharmaceutical, nutraceutical, and cosmetic supply chains globally.

In nutraceutical and dietary supplement manufacturing, NMN is formulated into capsules, tablets, and sublingual powders targeting NAD+ replenishment. Cosmetic formulators incorporate it into anti-aging serums and moisturizing creams.

Its humectant properties and antioxidant activity support skin barrier function and formulation stability. Pharmaceutical and biotech researchers use NMN as an intermediate in the synthesis of NAD+ analogs.

It also serves as a reference standard in metabolic pathway studies and as a biochemical reagent in cell culture and enzymatic assay development within life sciences laboratories and research facilities.

NMN is supplied as a white to off-white crystalline powder. Standard commercial grades include 98%+ purity material suitable for research and supplement applications, with higher-specification pharmaceutical-grade material available.

Bulk quantities are typically offered alongside smaller research-scale packaging to serve both industrial formulators and laboratory procurement needs. All batches are tested to ensure they meet strict quality standards.